Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO …

…, M Wakabayashi, S Nomura, A Sato… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE This is a phase Ib trial of regorafenib plus nivolumab for gastric and colorectal
cancer. PATIENTS AND METHODS Enrolled patients received regorafenib plus nivolumab in a …

High performance dye-sensitized solar cells using ionic liquids as their electrolytes

R Kawano, H Matsui, C Matsuyama, A Sato… - … of Photochemistry and …, 2004 - Elsevier
Room temperature ionic liquids have been used as electrolytes to investigate the performance
and the characteristics in dye-sensitized solar cells (DSSCs). The ionic liquids used are 1-…

A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708)

H Kato, A Sato, H Fukuda, Y Kagami… - Japanese journal of …, 2009 - academic.oup.com
Objective The study objective was to evaluate the efficacy and toxicity of chemoradiotherapy
with 5-fluorouracil (5-FU) plus cisplatin in patients with Stage I esophageal squamous cell …

[HTML][HTML] Non-equilibrium steady states in supramolecular polymerization

A Sorrenti, J Leira-Iglesias, A Sato… - Nature …, 2017 - nature.com
Living systems use fuel-driven supramolecular polymers such as actin to control important
cell functions. Fuel molecules like ATP are used to control when and where such polymers …

Effects of irradiation distance on supply of reactive oxygen species to the bottom of a Petri dish filled with liquid by an atmospheric O2/He plasma jet

…, A Kudo, T Sakanoshita, T Tsurumaru, A Sato… - Journal of Applied …, 2016 - pubs.aip.org
The impact of irradiation distances on plasma jet-induced specific effects on the supply of
reactive oxygen species (ROS) to the bottom of a Petri dish filled with liquid was investigated …

Malignant Astrocytic Tumors: Clinical Importance of Apparent Diffusion Coefficient in Prediction of Grade and Prognosis1

…, M Watanabe, S Mugikura, A Umetsu, A Sato… - Radiology, 2006 - pubs.rsna.org
Purpose: To retrospectively assess the apparent diffusion coefficient (ADC) for prediction of
malignancy and prognosis of malignant astrocytic tumors. Materials and Methods: The …

[HTML][HTML] Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

…, T Asakawa, S Olsen, JI Odegaard, A Sato… - Nature medicine, 2021 - nature.com
The applicability of circulating tumor DNA (ctDNA) genotyping to inform enrollment of patients
with cancer in clinical trials has not been established. We conducted a phase 2 trial to …

Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

…, K Tsuchihara, G Ishii, S Nomura, A Sato… - The Lancet …, 2017 - thelancet.com
Background RET rearrangements are rare oncogenic alterations in non-small-cell lung cancer
(NSCLC). Vandetanib is a multitargeted tyrosine kinase inhibitor exhibiting RET kinase …

Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial

…, H Shima, N Fujishiro, T Higuchi, A Sato… - The Lancet …, 2020 - thelancet.com
Background Pembrolizumab, an anti-PD-1 antibody, results in tumour response in around
15% of patients with advanced gastric cancer who have a PD-L1 combined positive score of …

Quantitative vascular measurements in arterial occlusive disease

…, K Takase, H Rikimaru, M Tsuboi, T Yamada, A Sato… - Radiographics, 2005 - pubs.rsna.org
Accuracy in quantifying arterial occlusive disease requires an understanding of the relevant
technical considerations and familiarity with the strengths and weaknesses of various …